| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| 1 day | +7.19% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 2022-08-31 |
| Director/Board Member | 63 | 2021-06-18 | |
Vadims Telica
BRD | Director/Board Member | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21-08-03 | Sell | Chief Financial Officer | 97,424 | 0.6917% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.19% | +2.67% | - | - | 148M | |
| -0.17% | +1.61% | +16.42% | +85.22% | 48.69B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 36.38B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.19B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.04B | |
| -0.76% | +0.38% | +33.16% | +123.08% | 9.04B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.06B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7.09B | |
| +0.69% | +3.25% | +19.90% | +243.91% | 6.75B | |
| +5.45% | -7.36% | -17.93% | +13.17% | 6.1B | |
| Average | +1.25% | -0.42% | +22.98% | +84.66% | 16.15B | |
| Weighted average by Cap. | +0.35% | +0.09% | +29.83% | +90.70% |
Employees
2,191
Sector
Pharmaceuticals
Choose MarketScreener 
